IRIS UniCatt

Gori, Niccolo'
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.207
NA - Nord America 1.033
EU - Europa 608
SA - Sud America 219
AF - Africa 41
OC - Oceania 3
Totale 3.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 979
SG - Singapore 547
CN - Cina 272
BR - Brasile 179
VN - Vietnam 135
FR - Francia 111
DE - Germania 99
IT - Italia 96
SE - Svezia 69
GB - Regno Unito 55
HK - Hong Kong 39
FI - Finlandia 37
IN - India 37
JP - Giappone 35
ID - Indonesia 33
IE - Irlanda 32
CA - Canada 27
RU - Federazione Russa 24
KR - Corea 22
PL - Polonia 22
MX - Messico 20
SA - Arabia Saudita 17
BD - Bangladesh 13
AR - Argentina 12
IQ - Iraq 12
NL - Olanda 12
ZA - Sudafrica 12
PK - Pakistan 11
CI - Costa d'Avorio 10
AT - Austria 8
ES - Italia 8
BO - Bolivia 6
EC - Ecuador 6
KE - Kenya 6
VE - Venezuela 6
MA - Marocco 5
TR - Turchia 5
AL - Albania 4
BE - Belgio 4
CY - Cipro 4
CZ - Repubblica Ceca 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DZ - Algeria 3
HR - Croazia 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MY - Malesia 2
PH - Filippine 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
Totale 3.111
Salva come PNG Salva come JPEG
Città #
Singapore 297
San Jose 151
Chandler 122
Ashburn 111
Beijing 59
Hefei 55
Ho Chi Minh City 44
Frankfurt am Main 39
Lauterbourg 38
New York 38
Hong Kong 36
Los Angeles 35
Tokyo 32
Dublin 31
Jakarta 30
Milan 30
Hanoi 28
Helsinki 24
Munich 22
Rome 20
Seoul 20
Council Bluffs 18
Dallas 18
Kent 18
London 18
St Louis 18
Boston 16
Bremen 16
Paris 16
Warsaw 15
São Paulo 14
Moscow 13
Amsterdam 12
Hangzhou 12
Princeton 12
Chicago 11
The Dalles 11
Abidjan 10
Jeddah 10
Montreal 10
Santa Clara 10
Nuremberg 9
Brooklyn 8
Da Nang 8
Denver 8
Roubaix 8
Stockholm 8
Boydton 7
Hyderabad 7
Lappeenranta 7
Mexico City 7
Chennai 6
Curitiba 6
Manchester 6
Nairobi 6
Orem 6
Ottawa 6
Portsmouth 6
Pune 6
Redwood City 6
Toronto 6
Turku 6
Wilmington 6
Wroclaw 6
Atlanta 5
Boardman 5
Falkenstein 5
Haiphong 5
Mumbai 5
Rio de Janeiro 5
San Mateo 5
Southampton 5
Vienna 5
Washington 5
Baghdad 4
Brussels 4
Düsseldorf 4
Johannesburg 4
La Paz 4
Nicosia 4
North Bergen 4
San Francisco 4
Bexley 3
Bắc Ninh 3
Bến Tre 3
Caracas 3
Charlotte 3
Chiyoda-ku 3
Cleveland 3
Faisalabad 3
Indaiatuba 3
Medina 3
Panama City 3
Phoenix 3
Poplar 3
Porto Alegre 3
Querétaro 3
Quito 3
Redmond 3
Riyadh 3
Totale 1.831
Salva come PNG Salva come JPEG
Nome #
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 122
Assessment of alopecia areata universalis successfully treated with upadacitinib 120
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 114
Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo 112
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 112
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 110
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib 109
Biological agents targeting interleukin-13 for atopic dermatitis 109
Evaluation of Upadacitinib efficacy in the treatment of Atopic Dermatitis of sensitive areas 103
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 100
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 100
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era 98
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab 95
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 95
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 93
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 93
Gianotti-Crosti Syndrome after SARS-CoV-2 infection 91
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 91
A case of disseminated perforating necrobiosis lipoidica 90
Leser-Trélat sign as a rare manifestation of cutaneous melanoma 85
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment 82
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 82
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 81
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 79
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 78
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 76
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 72
A case of guttate psoriasis during treatment with dupilumab 72
Polymorphic Skin Eruption in a Middle-Aged Man: A Quiz 70
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 66
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 66
Annular elastolytic giant cell granuloma following herpes zoster infection 66
Patient Satisfaction with Calcipotriol/Betamethasone Dipropionate Cream in Psoriatic Patients Previously Treated With Foam Vehicle 62
Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis” 60
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis 58
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us? 53
Totale 3.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 6 1
2021/202271 2 0 0 3 4 2 4 6 0 7 18 25
2022/2023342 27 45 23 53 25 37 23 45 46 3 13 2
2023/2024311 14 41 47 29 23 38 23 7 11 8 39 31
2024/2025709 11 10 58 13 72 32 25 15 83 75 189 126
2025/20261.692 227 68 128 236 296 86 315 89 108 133 6 0
Totale 3.165